Brief: Aurobindo Pharma Receives Final US FDA Approval For Tofacitinib Tablets, 5 Mg And 10 Mg
04/06/2026 14:36
BRIEF-Aurobindo Pharma Receives Final US FDA Approval For Tofacitinib Tablets, 5 Mg And 10 Mg June 4 (Reuters) - Aurobindo Pharma Ltd ARBN.NS:
AUROBINDO PHARMA - RECEIVES FINAL US FDA APPROVAL FOR TOFACITINIB TABLETS, 5 MG AND 10 MG
Source text: ID:nNSE3hZSH6
Further company coverage: ARBN.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11